Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Sanofi
Company Monitoring Page for Sanofi
latest headlines for company on cafepharma
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023
Fierce Pharma
Mon, 02/6/23 - 10:58 am
Tags:
Sanofi
,
Dupixent
,
earnings
Sanofi Admits Defeat for Myasthenia Gravis Candidate, Drops Phase III Trial
BioSpace
Fri, 02/3/23 - 10:31 am
Tags:
Sanofi
,
tolebrutinib
,
myasthenia gravis
New competitors push Sanofi to offer voluntary retirement packages at two Indian sites
Endpoints
Tue, 01/31/23 - 11:20 pm
Tags:
Sanofi
,
India
,
drug manufacturing
AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
Endpoints
Mon, 01/30/23 - 05:58 pm
Tags:
AstraZeneca
,
Sanofi
,
Novo Nordisk
,
340B
,
drug discounts
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
Tags:
television ads
,
pharma marketing
,
DTC ads
,
AbbVie
,
Rinvoq
,
Dupixent
,
Sanofi
,
Regeneron
,
Skyrizi
,
Novo Nordisk
,
Ozempic
,
Jardiance
,
Eli Lilly
,
Boehringer Ingelheim
,
Rybelsus
,
Trulicity
,
Rexulti
,
Otsuka
,
Lundbeck
,
Tremfya
,
JNJ
,
Verzenio
Sanofi dives deeper into phase 3 data for Hemlibra rival as FDA decision approaches
Fierce Biotech
Thu, 01/26/23 - 10:47 am
Tags:
Sanofi
,
FDA
,
clinical trials
,
hemophilia A
,
efanesoctocog alfa
,
Roche
,
Hemlibra
Sanofi takes to TikTok and Instagram to target millennials and older Gen Z parents for RSV education
Endpoints
Wed, 01/25/23 - 10:51 pm
Tags:
Sanofi
,
social media
,
TikTok
,
Instagram
,
RSV
,
pharma marketing
Sanofi promises money back for discontinued blood disorder treatment – in some cases
Endpoints
Mon, 01/23/23 - 10:00 pm
Tags:
Sanofi
,
drug warranty programs
,
Cablivi
,
aTTP
Sanofi and CytoReason target IBD in expanded collaboration
Pharma Live
Mon, 01/23/23 - 11:03 am
Tags:
Sanofi
,
CytoReason
,
IBD
,
R&D
JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor
BioPharma Dive
Wed, 01/11/23 - 11:08 pm
Tags:
JPMHC 2023
,
Takeda
,
Bristol Myers Squibb
,
Prime Medicine
,
Sanofi
Sanofi extends commitment to $750M biotech startup fund
Endpoints
Wed, 01/11/23 - 10:55 pm
Tags:
Sanofi
,
Sanofi Ventures
,
funding
JPM23: Sanofi has reached the 'steady state' Paul Hudson envisioned years ago, CEO says
Fierce Pharma
Wed, 01/11/23 - 10:54 am
Tags:
JPMHC 2023
,
Sanofi
,
Paul Hudson
,
Pharma CEOs
,
Dupixent
JPM Day 2: Highlights
BioSpace
Tue, 01/10/23 - 06:50 pm
Tags:
JPMHC 2023
,
Relay Therapeutics
,
Sanofi
,
Scholar Rock
,
SAGE Therapeutics
,
Karuna Therapeutics
,
GSK
What This Drug News Could Mean for Sanofi Shareholders
Motley Fool
Sun, 01/8/23 - 10:13 pm
Tags:
Sanofi
,
Dupixent
FDA starts review of Sanofi, AZ antibody for RSV prevention
Pharmaphorum
Thu, 01/5/23 - 10:20 am
Tags:
RSV
,
Sanofi
,
AstraZeneca
,
FDA
,
antibodies
,
nirsevimab
Biopharmas left Black and Latinx patients behind in oncology clinical trials, nonprofit says
Fierce Biotech
Thu, 01/5/23 - 10:09 am
Tags:
clinical trials
,
clinical trial diversity
,
oncology
,
Sanofi
,
United Therapeutics
,
Bristol Myers Squibb
Sanofi expects Zantac arbitration case with Boehringer Ingelheim to be resolved early this year
Endpoints
Wed, 01/4/23 - 05:16 pm
Tags:
Sanofi
,
Boehringer Ingelheim
,
Zantac
,
legal
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Tags:
Amgen
,
Sanofi
,
Regeneron
,
Supreme Court
,
legal
,
innovation
,
patents
,
Repatha
,
Praluent
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
Tags:
clinical trials
,
Alzheimer's disease
,
obesity
,
Huntington's disease
,
M&A
,
AstraZeneca
,
Daiichi Sankyo
,
Nimbus Therapeutics
,
Takeda
,
Eli Lilly
,
Sanofi
,
Regeneron
,
Moderna Therapeutics
,
Gilead Sciences
,
Pfizer
,
Roivant
,
Alnylam
,
uniQure
Could This Drug News Give a Lift to Eli Lilly Stock?
Motley Fool
Mon, 01/2/23 - 06:27 pm
Tags:
Eli Lilly
,
Rezvoglar
,
diabetes
,
Sanofi
,
Lantus
,
biosimilars
,
long-acting insulin
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.